ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 77 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $281,460 | +77866.8% | 78,620 | -52.6% | 0.00% | – |
| Q1 2023 | $361 | -93.9% | 165,770 | -66.2% | 0.00% | -100.0% |
| Q4 2022 | $5,897 | -99.8% | 490,203 | -2.6% | 0.00% | +50.0% |
| Q3 2022 | $3,260,000 | +22.6% | 503,031 | -13.3% | 0.00% | 0.0% |
| Q2 2022 | $2,658,000 | -15.5% | 580,383 | +59.6% | 0.00% | 0.0% |
| Q1 2022 | $3,145,000 | -71.1% | 363,560 | -52.3% | 0.00% | -66.7% |
| Q4 2021 | $10,875,000 | +615.0% | 761,570 | +1000.8% | 0.01% | +500.0% |
| Q3 2021 | $1,521,000 | -43.5% | 69,186 | -65.6% | 0.00% | -50.0% |
| Q2 2021 | $2,692,000 | +69.7% | 201,220 | +28.9% | 0.00% | +100.0% |
| Q1 2021 | $1,586,000 | +1486.0% | 156,122 | +563.9% | 0.00% | – |
| Q4 2020 | $100,000 | -45.4% | 23,517 | -66.4% | 0.00% | – |
| Q3 2020 | $183,000 | +357.5% | 70,084 | +435.4% | 0.00% | – |
| Q1 2020 | $40,000 | -20.0% | 13,091 | -17.0% | 0.00% | – |
| Q3 2019 | $50,000 | -65.0% | 15,772 | -0.5% | 0.00% | – |
| Q4 2017 | $143,000 | +2.1% | 15,849 | -5.7% | 0.00% | – |
| Q2 2016 | $140,000 | +13.8% | 16,811 | +17.0% | 0.00% | – |
| Q4 2015 | $123,000 | – | 14,364 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MORGAN JESS S & CO INC | 576,317 | $1,504,000 | 1.50% |
| Phoenix Holdings Ltd. | 197,763 | $483,000 | 0.02% |
| Frontier Wealth Management LLC | 71,900 | $188,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 19,659 | $51,000 | 0.01% |
| Rossmore Private Capital | 15,061 | $39,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 98,486 | $255,000 | 0.01% |
| Virtu Financial LLC | 10,450 | $27,000 | 0.01% |
| BOURGEON CAPITAL MANAGEMENT LLC | 5,627 | $15,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 3,150 | $8,000 | 0.00% |
| Qube Research & Technologies Ltd | 75,395 | $197,000 | 0.00% |